Dose-dependent association between morphine requirement and mortality risk after resection for hepatocellular carcinoma

Eur J Anaesthesiol. 2021 May 1;38(5):548-550. doi: 10.1097/EJA.0000000000001299.

Authors

Hsiang-Ling Wu¹, Ying-Hsuan Tai, Kuang-Yi Chang, Shih-Pin Lin

Affiliation

¹ From the Department of Anaesthesiology, Taipei Veterans General Hospital (HLW, YHT, KYC, SPL), The School of Medicine, National Yang-Ming University, Taipei (HLW, YHT, KYC, SPL), the Department of Anaesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City (YHT) and the Department of Anaesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan (YHT).

PMID: 33821833
DOI: 10.1097/EJA.0000000000001299

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular* / surgery
Hepatectomy / adverse effects
Humans
Liver Neoplasms* / surgery
Morphine / adverse effects
Retrospective Studies

Substances

Morphine